On Wednesday, Shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), lost -5.81% to $0.0697. 28.93 million shares of the company were exchanged.
Aeterna Zentaris Inc. (AEZS), declared the departure of Dennis Turpin , the Company’s former Senior Vice President, Chief Financial Officer, and the decision to close its Quebec City office.
David A. Dodd , Chairman, President and Chief Executive Officer of the Company commented, “After a comprehensive review, the Company’s Board reached the decision to take these actions, counting the closure of our Quebec City office by the end of December, making all associates based there redundant. We will transfer many of the functions now performed in our Quebec City office to other personnel and we will strengthen our financial team with the addition of new finance and accounting personnel in our Charleston, South Carolina office. A comprehensive search for a Chief Financial Officer and the other finance and accounting personnel required is underway. Mr. Keith Santorelli , our Vice President, Finance, will succeed Mr. Turpin as our Chief Accounting Officer, with responsibility for all internal and external financial reporting on an interim basis while the Company conducts an external search for a permanent CFO. We appreciate Keith’s leadership and commitment to ensuring a smooth transition in our finance and accounting function.”
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women’s health.
Shares of Merck & Co., Inc. (NYSE:MRK), surged 0.16% to $49.55, during its last trading session.
The share price of this stock traded recently in a range of $49.45 to $50.12. The company now has a market value of $139.34 billion.
For this company, beta value at 0.59 represents it is more volatile to the shift in the market. If we take a look on its volatility, 2.11% was seen in a week and for the month it was 2.45%.
A former Merck & Co Inc employee was sentenced to more than three years in prison on Tuesday for engaging in an insider trading scheme by tipping a friend at Bank of New York Mellon Corp about potential pharmaceutical mergers, according to Reuters.
Zachary Zwerko, a former senior finance analyst at Merck who was involved with performing work on potential corporate deals, was also ordered by U.S. District Judge Alvin Hellerstein in Manhattan to pay more than $694,000.
The case was the latest in a string of insider trading prosecutions pursued under Manhattan U.S. Attorney Preet Bharara, whose office confirmed Zwerko’s sentence. Bharara’s office since 2009 has secured convictions of 83 people.
Zwerko, of Cambridge, Massachusetts, was sentenced to 37 months in prison. He pleaded guilty to conspiracy and securities fraud charges in February. Reuters Reports
Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases.
Finally, Shares of IAMGOLD Corp (USA) (NYSE:IAG), ended its last trade with 11.83% gain, and closed at $2.08, as U.S. economic data missed economists forecasts, increasing doubts that the Fed will soon raise interest rates, the Wall Street Journal reports.
September sales went up 0.1% from August, falling short of economists’ forecasts of a 0.2% growth.
Having low interest rates is good for gold, but if rates go up, gold struggles to compete with yield-bearing investments, the Journal noted.
IAMGOLD Corporation will release its third quarter 2015 financial results after market hours on Tuesday, November 3rd, 2015.
CONFERENCE CALL
A conference call will be held on Wednesday, November 4th 2015, at 8:30 a.m. (Eastern Standard Time) for a talk about with administration regarding the Company’s operating performance and financial results for the third quarter of 2015. A webcast of the conference call will be accessible through the Company’s website – www.iamgold.com.
IAMGOLD Corporation primarily engages in the exploration, development, and operation of gold mining properties. It also explores for silver and copper deposits.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
